Companies/Integrum AB
Follow

Integrum AB

Nasdaq First North GM Stockholm (Sweden)

Integrum provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
Go to market

Sector:
HEALTH CARE
>
Medical Instruments & Supplies
Healthcare
Current instruments
Type
Ticker
ISIN
SHARE
INTEG B
SE0009807266
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
INTEG B
SE0009807266
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Integrum AB with ticker INTEG B
Status
Active
Currency
SEK
First trading date
15 May 2017
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Private placement
Sign in to buy
Private placement
Sign in to buy
Directed issue
Sign in to buy
People
Rickard Brånemark
CEO
Bengt Sjöholm
Chairman of the board
Patric Lindgren
Board member
Andrew Christensen
Board member
Cecilia Wikström
Board member
Karin Wingstrand
Board member
Artur Aira
Board member
Scott Flora
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Gemenskapens gata 9
Zip code
431 53
City/district
Mölndal
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556407-3145
LEI code
549300L5CG5PX4514U49
First trade date
15 May 2017
Registration date
08 Oct 1990
Short name
INTEG

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More